 ganciclovir recombin human granulocyte-macrophag colony-stimul factor treatment cytomegaloviru retin aid patient ganciclovir effect progress cytomegaloviru cmv retin patient immun defici syndrom aid develop neutropenia interrupt ganciclovir therapi aid patient ongo random trial aid patient cmv retin standard ganciclovir therapi ganciclovir recombin human granulocyte-macrophag colony-stimul factor rhugm-csf rhugm-csf subcutan inject dose neutrophil respons individu patient preliminari data evalu patient ganciclovir ganciclovir rhugm-csf rhugm-csf administr trend decreas proport patient absolut neutrophil count anc cells/microlit overal incid neutropen episod durat ganciclovir treatment interrupt due develop anc cells/microlit day day rhugm-csf administr consist prolif effect agent human immunodefici viru infect definit conclus coadministr rhugm-csf ganciclovir complet trial